Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Apr;10(2):158-74.
doi: 10.1177/1753465815618113. Epub 2015 Nov 26.

The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma

Richard Hewitt  1 , Hugo Farne  1 , Andrew Ritchie  1 , Emma Luke  2 , Sebastian L Johnston  1 , Patrick Mallia  3
Affiliations
Review

The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma

Richard Hewitt et al. Ther Adv Respir Dis. 2016 Apr.

Abstract

Asthma and chronic obstructive pulmonary disease (COPD) are major causes of global morbidity and mortality worldwide. The clinical course of both asthma and COPD are punctuated by the occurrence of exacerbations, acute events characterized by increased symptoms and airflow obstruction. Exacerbations contribute most of the morbidity, mortality and excess healthcare costs associated with both asthma and COPD. COPD and asthma exacerbations are frequently associated with respiratory virus infections and this has led to an intense research focus into the mechanisms of virus-induced exacerbations over the past decade. Current therapies are effective in reducing chronic symptoms but are less effective in preventing exacerbations, particularly in COPD. Understanding the mechanisms of virus-induced exacerbation will lead to the development of new targeted therapies that can reduce the burden of virus-induced exacerbations. In this review we discuss current knowledge of virus-induced exacerbations of asthma and COPD with a particular focus on mechanisms, human studies, virus-bacteria interactions and therapeutic advances.

Keywords: COPD; asthma; bacteria; respiratory viruses.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Novel approaches to treating virus-induced exacerbations of asthma and COPD.
See this image and copyright information in PMC

Comment in

References

    1. Albert R., Connett J., Bailey W., Casaburi R., Cooper J., Jr, Criner G., et al. (2011) Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365: 689–698. - PMC - PubMed
    1. Almansa R., Sanchez-Garcia M., Herrero A., Calzada S., Roig V., Barbado J., et al. (2011) Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease. J Interferon Cytokine Res 31: 409–413. - PubMed
    1. Arden K., Chang A., Lambert S., Nissen M., Sloots T., Mackay I. (2010) Newly identified respiratory viruses in children with asthma exacerbation not requiring admission to hospital. J Med Virol 82: 1458–1461. - PubMed
    1. Bafadhel M., McKenna S., Terry S., Mistry V., Reid C., Haldar P., et al. (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 184: 662–671. - PubMed
    1. Baines K., Hsu A., Tooze M., Gunawardhana L., Gibson P., Wark P. (2013) Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Respir Res 14: 15. - PMC - PubMed

MeSH terms